Hi guys,
When making estimates for revenue in future years, what do you guys take into consideration? (I'm talking about Clinical Trials only).
I mean, I know that digitization is the future, but what is a reasonable growth rate? 5%? 10%?
How many trials are inside the current $56 million of backlog? Is it 5? 10? And how many AD related trials will there be in the next 10 years?
How can the ruling on Aducanumab influence the number of trials in the next 10 years?
Thanks mates
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.84 |
Change
0.050(2.79%) |
Mkt cap ! $312.3M | |||
| Open | High | Low | Value | Volume |
| $1.81 | $1.84 | $1.79 | $19.96K | 11.05K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2500 | $1.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.84 | 1424 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| CGS (ASX) Chart |